The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05047146

Enrollment

530

Registered

2021-09-16

Start date

2021-01-01

Completion date

2022-07-31

Last updated

2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

This study aimed at study the clinical and pathological criteria of Hepatocellular carcinoma to keep with new challenging in diagnosis and morpho-molecular classifications

Interventions

OTHERMorphological classifications of HCC

Morphological classifications of Hepatocellular carcinoma

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* All pathologically proven Hepatocellular Carcinoma

Exclusion criteria

* Other malignant tumors than Hepatocellular Carcinoma * Benign tumor

Design outcomes

Primary

Measure	Time frame	Description
Clinicopathological factors of Hepatocellular Carcinoma	10 years	Serum alpha-fetoprotein (AFP) level

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026